Search Results - Cherbavaz, Diana B

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect

    Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect by Magi-Galluzzi, Cristina, Maddala, Tara, Falzarano, Sara Moscovita, Cherbavaz, Diana B., Zhang, Nan, Knezevic, Dejan, Febbo, Phillip G., Lee, Mark, Lawrence, Hugh Jeffrey, Klein, Eric A.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies

    Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies by Knezevic, Dejan, Goddard, Audrey D, Natraj, Nisha, Cherbavaz, Diana B, Clark-Langone, Kim M, Snable, Jay, Watson, Drew, Falzarano, Sara M, Magi-Galluzzi, Cristina, Klein, Eric A, Quale, Christopher

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Characterization and Functionality of Proliferative Human Sertoli Cells

    Characterization and Functionality of Proliferative Human Sertoli Cells by Chui, Kitty, Trivedi, Alpa, Cheng, C. Yan, Cherbavaz, Diana B., Dazin, Paul F., Huynh, Ai Lam Thu, Mitchell, James B., Rabinovich, Gabriel A., Noble-Haeusslein, Linda J., John, Constance M.

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial)

    The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubici... by Penault-Llorca, Frédérique, Filleron, Thomas, Asselain, Bernard, Baehner, Frederick L., Fumoleau, Pierre, Lacroix-Triki, Magali, Anderson, Joseph M., Yoshizawa, Carl, Cherbavaz, Diana B., Shak, Steven, Roca, Lise, Sagan, Christine, Lemonnier, Jérôme, Martin, Anne-Laure, Roché, Henri

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

    A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast by Solin, Lawrence J., Gray, Robert, Baehner, Frederick L., Butler, Steven M., Hughes, Lorie L., Yoshizawa, Carl, Cherbavaz, Diana B., Shak, Steven, Page, David L., Sledge, George W., Davidson, Nancy E., Ingle, James N., Perez, Edith A., Wood, William C., Sparano, Joseph A., Badve, Sunil

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy

    21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy by Mamounas, Eleftherios P., Liu, Qing, Paik, Soonmyung, Baehner, Frederick L., Tang, Gong, Jeong, Jong-Hyeon, Kim, S. Rim, Butler, Steven M., Jamshidian, Farid, Cherbavaz, Diana B., Sing, Amy P., Shak, Steven, Julian, Thomas B., Lembersky, Barry C., Wickerham, D. Lawrence, Costantino, Joseph P., Wolmark, Norman

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: Results from NSABP B-28/NRG Oncology

    21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: Results from NSABP B-28/NRG Oncology by Mamounas, Eleftherios P., Tang, Gong, Paik, Soonmyung, Baehner, Frederick L., Liu, Qing, Jeong, Jong-Hyeon, Kim, Seong-Rim, Butler, Steven M., Jamshidian, Farid, Cherbavaz, Diana B., Sing, Amy P., Shak, Steven, Julian, Thomas B., Lembersky, Barry C., Wickerham, D. Lawrence, Costantino, Joseph P., Wolmark, Norman

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ

    Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ by Rakovitch, Eileen, Nofech-Mozes, Sharon, Hanna, Wedad, Sutradhar, Rinku, Baehner, Frederick L., Miller, Dave P., Fong, Cindy, Gu, Sumei, Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A., Bonin, Michel, Chang, Martin C., Slodkowska, Elzbieta, Anderson, Joseph M., Cherbavaz, Diana B., Shak, Steven, Paszat, Lawrence

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study

    Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study by Iwata, Hiroji, Masuda, Norikazu, Yamamoto, Yutaka, Fujisawa, Tomomi, Toyama, Tatsuya, Kashiwaba, Masahiro, Ohtani, Shoichiro, Taira, Naruto, Sakai, Takehiko, Hasegawa, Yoshie, Nakamura, Rikiya, Akabane, Hiromitsu, Shibahara, Yukiko, Sasano, Hironobu, Yamaguchi, Takuhiro, Sakamaki, Kentaro, Bailey, Helen, Cherbavaz, Diana B., Jakubowski, Debbie M., Sugiyama, Naoko, Chao, Calvin, Ohashi, Yasuo

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone

    A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone by Rakovitch, Eileen, Nofech-Mozes, Sharon, Hanna, Wedad, Baehner, Frederick L., Saskin, Refik, Butler, Steven M., Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A., Bonin, Michel, Chang, Martin C., Robertson, Susan J., Slodkowska, Elzbieta, Fong, Cindy, Anderson, Joseph M., Jamshidian, Farid, Miller, Dave P., Cherbavaz, Diana B., Shak, Steven, Paszat, Lawrence

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: